Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Bevacizumab and Nimustine in Patients With Recurrent High Grade Glioma

NCT02698280 is registered in ClinicalTrials.gov with Huashan Hospital as lead sponsor.

NCT NCT02698280
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02698280 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Bevacizumab and Nimustine in Patients With Recurrent High Grade Glioma
Lead sponsor
Huashan Hospital
Phase
Phase 2
Overall status
Completed
Start date
July 31, 2015
Completion date
May 31, 2018
Enrollment
23 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glioblastoma